Medication info

Amidm M Tablet 2/500 mg

Prescription medicationExpired
Ingredient · strength
Metformin Hydrochloride›Strength being verifiedGlimepiride›Strength being verified
Manufacturer / importer
Pharmaking Co., Ltd.
Appearance
White, oblong film-coated tablet
Packaging
100 tablets/bottle, 30 tablets/PTP (10 tablets/PTP × 3)
Approval status
Expired

MFDS item code 201307083 · Approved 2013.04.26

This product's status changed to Expired on 2023.04.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This drug is administered 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and doses were gradually increased according to the results of blood glucose monitoring, up to glimepiride/metformin hydrochloride 8mg/2000mg. For glimepiride as a single agent, there is generally little additional effect at doses above 4mg daily, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as an alternative to combination therapy, administer according to the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose is missed, do not take more than a single dose at the next scheduled administration.

Ingredients

Manufacturer
Pharmaking Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medicine is used for patients with insulin-independent diabetes, specifically type 2 diabetes. It is particularly used in conjunction with dietary and exercise therapy but is effective when glymepiride or metformin alone is insufficient for blood sugar control. It is also noted that it can substitute for combination therapy of glymepiride and metformin. It effectively controls blood sugar to assist in diabetes management.

Dosage and Administration

Adult dosage

This drug is administered 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and doses were gradually increased according to the results of blood glucose monitoring, up to glimepiride/metformin hydrochloride 8mg/2000mg. For glimepiride as a single agent, there is generally little additional effect at doses above 4mg daily, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as an alternative to combination therapy, administer according to the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose is missed, do not take more than a single dose at the next scheduled administration.

Precautions

This drug may cause severe lactic acidosis or hypoglycemia; therefore, administration should be temporarily stopped and a doctor consulted if there is a sudden decline in kidney function or symptoms of dehydration. It should not be administered to patients with decreased kidney function or severe liver dysfunction, pregnant or breastfeeding women, and patients who will undergo specific tests or surgery. Given the risk of hypoglycemia, special caution is required when nutritional status is poor, meals are skipped, strenuous exercise is undertaken, or excessive alcohol is consumed. Gastrointestinal symptoms such as diarrhea, nausea, and vomiting may occur initially, but they are usually temporary and can be reduced by taking the medication with food. If allergic reactions or severe skin rashes, difficulty breathing, or other symptoms occur, seek immediate medical attention, and regular blood tests should be conducted to check for anemia or liver dysfunction. This medicine may interact with other drugs; therefore, it is essential to inform your doctor or pharmacist of any other medications being taken. Pregnant women or those planning pregnancy are recommended to switch to insulin therapy instead of using this medication. Children and the elderly require careful assessment and ongoing monitoring before use. In cases of overdose, hypoglycemic symptoms may appear, so contact a medical facility immediately, and emergency measures such as administering glucose should be initiated if necessary. Caution is necessary when driving or operating machinery due to the risk of accidents from hypoglycemia or dizziness. This medication should be stored out of reach of children and should not be transferred to other containers.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
Show 68 more
  • metallic taste
  • visual impairment
  • erythema
  • itching
  • urticaria
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythrocytopenia
  • neutropenia
  • agranulocytosis
  • pancytopenia
  • megaloblastic anemia
  • increased liver enzymes
  • liver dysfunction
  • cholestatic jaundice
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity of the skin
  • decreased serum sodium concentration
  • abdominal pain
  • abdominal distension
  • vomiting
  • indigestion
  • palpitations
  • dizziness
  • diarrhea
  • nausea
  • leg edema
  • cardiac arrest
  • rectal carcinoma
  • hypoglycemia
  • headache
  • severe hunger
  • fatigue
  • sleep
  • weakness
  • drowsiness
  • sleep disturbances
  • instability
  • aggression
  • attentional deficit
  • inability to concentrate
  • abnormal reactions
  • depression
  • confusion
  • aphasia
  • language loss
  • visual disturbances
  • tremors
  • paralysis
  • sensory disturbances
  • inability to self-regulate
  • delirium
  • cerebral convulsions
  • loss of consciousness
  • coma
  • weak breathing
  • slow pulse
  • sweating
  • moist skin
  • anxiety
  • rapid pulse
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure. The storage temperature should ideally be maintained between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White, oblong film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/PTP (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.